North China Pharmaceutical Company. Ltd. provided earnings guidance for 2017. The company predicts a year-on-year decrease of between RMB 27 million and RMB 38 million in its net profit owned by shareholders of the listed company in 2017, a year-on-year decrease of between 50% and 70%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will increase by between RMB 69 million and RMB 80 million, compared with loss of RMB 51.2259 million of the same period of the year before.